All Insights
Showing 1 - 12 of 220
Life Sciences and Healthcare
Planned EU medtech changes and codified Helsinki procedure support consistent qualification and classification
EU coordination, expert panel opinions and targeted down classification are proposed to harmonise risk based outcomes
Corporate
Confidence in a changing global market: 2025 dealmaking themes and 2026 market opportunities
The global transactional market demonstrated resilience amid complexity in 2025 as it staged a measured recovery
Life Sciences and Healthcare
What will shape European life sciences and healthcare in 2026?
There will be comprehensive regulatory changes across the UK and EU, with streamlined approval pathways alongside heightened governance and compliance
Life Sciences and Healthcare
EU drug agency to take broader coordinating role in devices and diagnostics in latest proposal
Expert panel support, shortage coordination and combined study procedures strengthen the EMA's oversight of devices
Intellectual property
What does 2026 augur for AI and IP in Europe?
AI and copyright appeals set to take centre stage, with a consultation response promised from the UK government and a
Regulatory Outlook
Artificial intelligence | UK Regulatory Outlook January 2026
UK: AI and copyright | UK AI bill | EU: EU AI Act | Digital omnibus on AI | Labelling
Regulatory Outlook
Advertising and marketing | UK Regulatory Outlook January 2026
Influencer marketing | AI disclosure and enforcement | Protection of children | Price transparency under the DMCCA | Subscriptions |
Knowledge Notes
What business law changes can the UK expect in 2026?
Osborne Clarke's Knowledge Team looks at what's in store for business
Financial Services
European Parliament recommends clear, proportionate rules and supervisory coordination for AI in financial services
Resolution reiterates risk-based approach and frames expectations on how the AI Act will be interpreted and implemented
Life Sciences and Healthcare
Medical devices, diagnostics and pharma win concessions in EU Digital Omnibus proposal
Commission acknowledges implementation challenges, adjusts high-risk AI requirements for the life sciences sector
Regulatory Outlook
Artificial intelligence | UK Regulatory Outlook November 2025
UK: Landmark UK AI and IP case: Getty Images v Stability AI | Select Committee opens inquiry on AI and
Life Sciences and Healthcare
UK's biotech sector builds global life sciences status
TechBio conference showcases UK world-class research and biotech innovation
